Scarica l'app Stockscreener
22.97
3.53%
-0.84
Pre-mercato:
23.00
0.03
+0.13%
Precedente Chiudi:
$23.81
Aprire:
$23.895
Volume 24 ore:
583.41K
Relative Volume:
2.07
Capitalizzazione di mercato:
$626.72M
Reddito:
$79.95M
Utile/perdita netta:
$-4.60M
Rapporto P/E:
-128.54
EPS:
-0.1787
Flusso di cassa netto:
$10.19M
1 W Prestazione:
+21.41%
1M Prestazione:
+25.66%
6M Prestazione:
+15.25%
1 anno Prestazione:
+55.31%
Intervallo 1D:
$22.85
$23.96
Intervallo di 1 settimana:
$18.82
$23.96
Portata 52W:
$11.09
$23.96
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Nome
Eton Pharmaceuticals Inc
Settore
Telefono
(847) 787-7361
Indirizzo
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
22.97 | 626.72M | 79.95M | -4.60M | 10.19M | -0.1787 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-23 | Reiterato | H.C. Wainwright | Buy |
| 2025-01-10 | Iniziato | B. Riley Securities | Buy |
| 2025-01-06 | Reiterato | H.C. Wainwright | Buy |
| 2024-09-04 | Ripresa | H.C. Wainwright | Buy |
| 2024-05-06 | Iniziato | Craig Hallum | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-01-04 | Reiterato | H.C. Wainwright | Buy |
| 2019-09-20 | Iniziato | B. Riley FBR | Buy |
| 2019-06-10 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Eton Pharmaceuticals Inc Borsa (ETON) Ultime notizie
Eton Pharmaceuticals (ETON) Jumps 6.7%: Does the Stock Have More Room to Grow? - Bitget
Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Does Eton Pharmaceuticals (ETON) have the potential to rally 49.25% as Wall Street analysts expect? - MSN
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week High After Analyst Upgrade - MarketBeat
Recent Price Trend in Eton Pharmaceuticals (ETON) is Your Friend, Here's Why - Yahoo Finance
H.C. Wainwright raises Eton Pharmaceuticals price target on growth goals By Investing.com - Investing.com Canada
Dow Update: Is Eton Pharmaceuticals Inc still a buy after recent gainsMarket Performance Report & Consistent Income Trade Recommendations - baoquankhu1.vn
Zacks Research Upgrades Eton Pharmaceuticals (NASDAQ:ETON) to Strong-Buy - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Rating Increased to Buy at Wall Street Zen - MarketBeat
Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path - TipRanks
Eton Pharmaceuticals receives Investment Bank Analyst Rating Update By Investing.com - Investing.com Canada
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
B. Riley Financial Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect? - sharewise.com
Does Eton Pharmaceuticals (ETON) Have a Chance to Surge 49.25% According to Wall Street Analysts' Predictions? - Bitget
B.Riley raises Eton Pharmaceuticals stock price target on strong Q4 results - Investing.com Canada
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript - Insider Monkey
Eton Pharma 2025 Financial Results & 2026 Outlook | Product Launches Drive GrowthNews and Statistics - IndexBox
Portfolio Update: Can Eton Pharmaceuticals Inc. lead its sector in growth2026 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Eton Pharmaceuticals 2023 Financial Results: Revenue, Net Income, and Key Financial Highlights - Minichart
Eton Pharmaceuticals (ETON) Turns Q4 Profit As Trailing Losses Test Bullish Growth Narrative - Sahm
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals 2025 Annual Report: Rare Disease Drug Portfolio, Regulatory Pathways, and Risk Factors Overview - Minichart
Is Eton Pharmaceuticals Inc a cyclical or defensive stock2026 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Eton Pharmaceuticals, Inc. (ETON) Q4 earnings lag estimates - MSN
Eton Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Eton Pharmaceuticals (NASDAQ:ETON) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Eton Pharmaceuticals, Inc. (ETON) Q4 Results Fall Short of Projections - Bitget
ETON: 2025 revenue more than doubled year-over-year, with strong margin gains and robust growth outlook - TradingView
Eton Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
Eton Pharma (ETON) Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Eton Pharmaceuticals Q4 2025 beats EPS, stock rises - Investing.com
Eton Pharmaceuticals earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Eton Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates - Yahoo Finance
ETON PHARMACEUTICALS ($ETON) Releases Q4 2025 Earnings - Quiver Quantitative
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
ETON: 2025 revenues doubled to $80M, but higher costs led to a net loss; growth expected ahead - TradingView
Eton Pharmaceuticals (NASDAQ: ETON) outlines rare-disease drugs, pipeline and IRA pricing risks - Stock Titan
Eton Pharmaceuticals (NASDAQ: ETON) posts strong 2025 growth and bullish 2026 outlook - Stock Titan
BRIEF-Eton Pharmaceuticals Q4 Net Income USD 1.483 Million - TradingView
Eton Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Eton Pharmaceuticals (NASDAQ:ETON) Shares Up 5.8%Time to Buy? - MarketBeat
Eton Pharmaceuticals Q4 2025 Earnings Call Transcript - MarketBeat
Analysts’ Top Healthcare Picks: Eton Pharmaceuticals (ETON), Zenas BioPharma, Inc. (ZBIO) - The Globe and Mail
Aug Outlook: What drives Eton Pharmaceuticals Incs stock priceDividend Hike & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Divisadero Street Capital Management LP Trims Stock Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Cannell Capital LLC Buys 67,230 Shares of Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Why (ETON) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Eton Pharmaceuticals Inc Azioni (ETON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):